Literature DB >> 32847869

Progressive multifocal leukoencephalopathy as the first presentation of sarcoidosis.

Maha Elbadri1, Gordon Plant2.   

Abstract

Recognition of progressive multifocal leukoencephalopathy (PML) in patients with an established primary neuroinflammatory condition can be clinically challenging. Delayed or incorrect diagnosis may worsen the course of the disease and result in an inaccurate prognosis. We present an unusual case of a patient with a rapid decline in visual acuity, positive serum ACE and extensive lymphadenopathy who was found to have progressive subcortical lesions and cerebrospinal fluid PCR positive for John Cunningham virus supporting a coincidental diagnosis of PML. The prognosis of PML is affected by the associated condition. Establishing the diagnosis is important for an exact prognosis of the primary condition but also to allow early discontinuation of immunomodulatory treatment. Sarcoidosis-associated PML might have a similar aggressive course to that seen when associated with haematological malignancies. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  infection (neurology); iris; visual pathway

Mesh:

Year:  2020        PMID: 32847869      PMCID: PMC7451273          DOI: 10.1136/bcr-2019-232636

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.

Authors:  Irene Cortese; Pawel Muranski; Yoshimi Enose-Akahata; Seung-Kwon Ha; Bryan Smith; MariaChiara Monaco; Caroline Ryschkewitsch; Eugene O Major; Joan Ohayon; Matthew K Schindler; Erin Beck; Lauren B Reoma; Steve Jacobson; Daniel S Reich; Avindra Nath
Journal:  N Engl J Med       Date:  2019-04-10       Impact factor: 91.245

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

3.  Predictive value of JC virus PCR in cerebrospinal fluid in the diagnosis of PML.

Authors:  Bart Swinnen; Veroniek Saegeman; Kurt Beuselinck; Anke Wouters; Gert Cypers; Geert Meyfroidt; Maarten Schrooten
Journal:  Diagn Microbiol Infect Dis       Date:  2019-06-26       Impact factor: 2.803

4.  Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tarek A Yousry; Daniel Pelletier; Diego Cadavid; Achim Gass; Nancy D Richert; Ernst-Wilhelm Radue; Massimo Filippi
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

Review 5.  Progressive multifocal leukoencephalopathy as the first manifestation of occult sarcoidosis: case report and review of the literature.

Authors:  Matthew J Davis; Adnan Khan; Walter Royal
Journal:  Neurologist       Date:  2013-01       Impact factor: 1.398

Review 6.  Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.

Authors:  Dejan Pavlovic; Andriani C Patera; Fredrik Nyberg; Marianne Gerber; Maggie Liu
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

7.  Asymptomatic reactivation of JC virus in patients treated with natalizumab.

Authors:  Yiping Chen; Evelyn Bord; Troy Tompkins; Janice Miller; Chen S Tan; R Philip Kinkel; Marion C Stein; Raphael P Viscidi; Long H Ngo; Igor J Koralnik
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

8.  Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tuan Dong-Si; Sarah Gheuens; Amy Gangadharan; Made Wenten; Jeffrey Philip; James McIninch; Shoibal Datta; Nancy Richert; Carmen Bozic; Gary Bloomgren; Sandra Richman; Thomas Weber; David B Clifford
Journal:  J Neurovirol       Date:  2015-03-14       Impact factor: 2.643

Review 9.  Progressive Multifocal Leukoencephalopathy: Current Insights.

Authors:  Marge Kartau; Jussi Ot Sipilä; Eeva Auvinen; Maarit Palomäki; Auli Verkkoniemi-Ahola
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-12-02

10.  Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature.

Authors:  Irene Gamperl; Christian Enzinger; Alexander Pichler; Michael Feichtinger; Thomas Schlager; Elisabeth Fertl
Journal:  Clin Case Rep       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.